PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Racial Gaps in Diabetes Adherence Persist Within Medicare Advantage Plans

★ Editor's PickmetformininsulinSGLT2 inhibitorsGLP-1 receptor agonistsdiabetesmedication adherencehealth disparitiesMedicare AdvantageLow-Income SubsidyMedicaidproportion of days coveredcohort studyhealth policyMTM Ambulatory Care / MTM

Background Information

Medication adherence in diabetes shows racial and ethnic disparities.

Medication adherence is crucial in managing diabetes, yet disparities in adherence may lead to adverse outcomes in racial and ethnic minority groups. Black and Hispanic patients demonstrated lower adherence to diabetes medications compared to White patients, with Medicaid and subsidies partially reducing these gaps. Findings underscore the need for targeted interventions to address adherence disparities, highlighting the potential role of Medicaid and community strategies. Enhanced insurance and community strategies are critical to reducing racial and ethnic disparities in diabetes medication adherence.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Essien UR, Roberts ET, Ruggiero DA, Tang JJ, Raghava S, Ayanian JZ, Tipirneni R

Citation: Essien UR, Roberts ET, Ruggiero DA, et al. Racial and Ethnic Disparities in Medication Adherence Among Medicare Advantage Enrollees With Diabetes. JAMA network open. 2026;9(9):e2634846. doi:10.1001/jamanetworkopen.2026.34846

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.